TMCnet News

ROTH 2007 New York Conference Presenter Profiles
[September 04, 2007]

ROTH 2007 New York Conference Presenter Profiles


NEW YORK --(Business Wire)-- ROTH 2007 New York Conference takes place Sept. 5 - 6, 2007 at The Westin New York. Listed below are ROTH 2007 New York Conference presenter profiles. For in-depth information about the event, visit http://www.rothcp.com/main/page.aspx?PageID=7010.



Business Wire is the official news wire for the ROTH 2007 New York Conference. Breaking news releases and photos are available at http://www.tradeshownews.com, Business Wire's trade show, conference, and event news resource.

Company:              Access Integrated Technologies,
                  Inc.
Ticker Symbol & Exchange:      NASDAQ: AIXD
Investor Relations Contact:     Suzanne Moore
Investor Relations Contact Phone:  973-290-0056
Web:                www.accessitx.com
Date of Presentation:        September 5, 2007 at 10:30 am
AccessIT provides theater operators the first and only studio-backed
fully networked digital cinema system delivering more than two
million digital screenings of Hollywood feature films to date. The
company's digital cinema system provides feature films and
alternative content via satellite to expand box office sales and
develop new ways to attract incremental revenues. Through its
alternative content division, The Bigger Picture, AccessIT offers
channels of programming including Kidtoons, Faith Based Anime and
South by Southwest, the first in a series of Bigger Concerts from The
Bigger Picture. The ongoing 4,000-screen deployment plan is the
largest of its kind in the world.
Company:              Advanced Photonix, Inc.
Ticker Symbol & Exchange:      API:AMEX
Investor Relations Contact:     Richard Moyer, Cameron Associates
Investor Relations Contact Phone:  212-554-5466
Web:                www.advancedphotonix.com
Date of Presentation:        September 5, 2007 @4:30pm ET
Advanced Photonix, Inc.(R) (AMEX: API) is a leading supplier of opto-
electronic solutions and Terahertz sensors and systems to a global
OEM customer base. Our solutions are based on our patented high speed
optical receivers in III-V materials in APD and PIN configurations,
and silicon Large Area Avalanche Photodiode (LAAPD), PIN photodiode
and FILTRODE(R) detectors. The Terahertz sensor product line is
targeted to the Non-Destructive Testing and process control markets,
which includes baggage/cargo scanning and quality control
applications. With a vertically integrated manufacturing process, API
supports the customer from the initial concept: designing the
semiconductor; hybridization of support electronics; packaging and
signal conditioning or processing from prototype through full-scale
production; and validation/test.
Company:              American Science & Engineering,
                  Inc.
Ticker Symbol & Exchange:      ASEI
Investor Relations Contact:     Annemarie Sadowski
Investor Relations Contact Phone:  978.262.8828
Web:                www.as-e.com
Date of Presentation:        6-Sep-07
American Science and Engineering, Inc. (AS&E) is the leading worldwide
supplier of innovative X-ray inspection systems. AS&E's product line
utilizes a combination of technologies, including patented Z
Backscatter technology, Radioactive Threat Detection (RTD), high
energy transmission and dual energy transmission X-ray. These
technologies offer superior X-ray threat detection for plastic
explosives, plastic weapons, liquid explosives, dirty bombs and
nuclear devices. AS&E's complete range of products include cargo
inspection systems for port and border security, baggage screening
systems for facility and aviation security, and personnel and
passenger screening systems. AS&E systems protect high-threat
facilities and help combat terrorism, trade fraud, drug smuggling,
weapon smuggling, and illegal immigration.
Company:              Amerigon Incorporated
Ticker Symbol & Exchange:      NASDAQ: ARGN
Investor Relations Contact:     Jill Bertotti
Investor Relations Contact Phone:  949-474-4300
Web:                www.amerigon.com
Date of Presentation:        9/5/2007
Amerigon develops products based on its advanced, proprietary,
efficient thermoelectric (TE) technologies for a wide range of global
markets and heating and cooling applications. The Company's current
principal product is its proprietary Climate Control Seat(TM)
(CCS(TM)) system, a solid-state, TE-based system that permits drivers
and passengers of vehicles to individually and actively control the
heating and cooling of their respective seats to ensure maximum year-
round comfort. CCS, which is the only system of its type on the
market today, uses no CFCs or other environmentally sensitive
coolants. Amerigon maintains sales and technical support centers in
Southern California, Detroit, Japan, Germany and England.
Company:              ANADIGICS
Ticker Symbol & Exchange:      ANAD, NASDAQ
Investor Relations Contact:     Kristina Panek
Investor Relations Contact Phone:  908-668-5000 x5330
Web:                www.anadigics.com
Date of Presentation:        6-Sep-07
ANADIGICS designs & manufactures radio frequency integrated circuit
solutions for the wireless and wireline communications markets.
ANADIGICS is a pure-play radio frequency integrated circuit company
featuring III-V GaAs, InGaP HBT and 6-inch GaAs fab and module
manufacturing. ANADIGICS developed a high-quality/performance brand
image and is a leader in 3G, WLAN, WCDMA/EDGE Power Amplifiers, and
maintains a #1 position in the cable subscriber and infrastructure
markets.
Company:              Auriga Laboratories
Ticker Symbol & Exchange:      ARGA - OTCBB
Investor Relations Contact:     Michael Wachs
Investor Relations Contact Phone:  212-732-4300
Web:                www.aurigalabs.com
Date of Presentation:        9/5 -3:30
Auriga Laboratories is a specialty pharmaceutical company building an
industry changing commission-based sales model. The company's
business model combines the acquisition of proven brand names,
introduction of new brands, and a strategic development pipeline, all
of which is designed to enhance its growing direct relationships with
physicians nationwide. Auriga's exclusive prescription and over-the-
counter product portfolio includes Aquoral(TM) for the treatment of
Xerostomia, Akurza(TM) and Xyralid(TM) dermatology products, and the
Zinx(TM), Extendryl(R), and Levall(R) families of products for relief
of symptoms associated with a range of acute respiratory diseases.
Company:              AXT, Inc.
Ticker Symbol & Exchange:      NASDAQ: AXTI
Investor Relations Contact:     Leslie Green
Investor Relations Contact Phone:  650-312-9060
Web:                www.axt.com
Date of Presentation:        9/6/2007
AXT designs, develops, manufactures and distributes high-performance
compound and single element semiconductor substrates comprising
gallium arsenide (GaAs), indium phosphide (InP) and germanium (Ge).
The company's substrate products are used primarily in lighting
display applications, wireless communications, and fiber optic
communications. Its vertical gradient freeze (VGF) technique for
manufacturing semiconductor substrates provides significant benefits
over other methods and enabled AXT to become a leading manufacturer
of such substrates, particularly in optoelectronics applications. AXT
has manufacturing facilities in China and invests in five joint
ventures producing raw materials.
Company:              Aware, Inc.
Ticker Symbol & Exchange:      AWRE
Investor Relations Contact:     Keith Farris
Investor Relations Contact Phone:  781-276-4000
Web:                http://www.aware.com
Date of Presentation:        Wed., September 5, 2007 @ 2:30PM
Aware is a leading technology supplier for the telecommunications
industries. For more than ten years, Aware has pioneered innovations
at telecommunications standards-setting organizations and continues
to develop and market DSL silicon intellectual property and test and
diagnostics products. Its StratiPHY(TM) IP product line supports DSL
standards and has been broadly licensed to leading semiconductor
companies. Telecom equipment vendors and phone companies use Aware's
DSL test and diagnostics modules and Dr. DSL(R) software to help
provision DSL circuits globally. Aware is also a veteran of the
biometrics industry, providing biometric and imaging software
components used in government systems worldwide since 1992.
Company:              Barrier Therapeutics, Inc.
Ticker Symbol & Exchange:      NASDAQ: BTRX
Investor Relations Contact:     Anne M. VanLent, EVP & CFO
Investor Relations Contact Phone:  (609) 945-1202
Web:                www.barriertherapeutics.com
Date of Presentation:        September 6, 2007 at 2:00p.m. EDT
Barrier Therapeutics, Inc., headquartered in Princeton, New Jersey, is
a pharmaceutical company focused on the development and
commercialization of dermatology products. Barrier Therapeutics
currently markets three pharmaceutical products in the United States:
Xolegel(TM) (ketoconazole, USP) Gel, 2%, for seborrheic dermatitis;
Vusion(R) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white
petrolatum) Ointment, for diaper dermatitis complicated by documented
candidiasis; and Solage(R) (mequinol 2.0%, tretinoin 0.01%) Topical
Solution, for solar lentigines. Barrier Therapeutics has other
product candidates in various stages of clinical development for the
treatment of various dermatological conditions, including
onychomycosis, psoriasis, acne, skin allergies, and acute fungal
infections.
Company:              Bidz.com
Ticker Symbol & Exchange:      NASDAQ: BIDZ
Investor Relations Contact:     Allyson Pooley
Investor Relations Contact Phone:  310-954-1100
Web:                www.bidz.com
Date of Presentation:        Sep. 6 - 12pm Eastern
Bidz.com, Inc. is a leading leading auctioneer of jewelry, featuring a
live auction format. Bidz has established its retail brand in the
online marketplace by offering high-quality merchandise, a unique
user-friendly shopping experience, and the opportunity for buyers to
achieve significant cost savings versus traditional retail channels.
Company:              Bio-Imaging Technologies, Inc.
Ticker Symbol & Exchange:      NASDAQ: BITI
Investor Relations Contact:     Linda Decker
Investor Relations Contact Phone:  (212) 546-4700
Web:                www.bioimaging.com
Date of Presentation:        6-Sep-07
Bio-Imaging Technologies, Inc. is a healthcare contract service
organization providing services that support the product development
process of the pharmaceutical, biotechnology and medical device
industries. The Company has specialized in assisting its clients in
the design and management of the medical-imaging component of
clinical trials since 1990. Bio-Imaging serves its clients on a
global basis through its US Core Lab in Newtown, PA, its European
Core Lab in Leiden, The Netherlands and its recent acquisition of
Theralys SA in Lyon, France. Through its CapMed division, Bio-Imaging
provides the Personal HealthKey(TM) technology and the Personal
Health Record (PHR) software allowing patients to better monitor and
manage their health care information.
Company:              Boo Koo Holdings, Inc.
Ticker Symbol & Exchange:      BOKO.OB
Investor Relations Contact:     Steve Ruffini
Investor Relations Contact Phone:  972-818-3862 ext 280
Web:                bookooenergy.com
Date of Presentation:        5-Sep-07
Boo Koo Holdings, Inc. is the parent public company for Boo Koo
Beverages, Inc. (Boo Koo). Boo Koo develops, produces, markets and
distributes alternative beverage category energy drinks under the Boo
Koo(R) brand name. Boo Koo currently sells and distributes its
products in 43 states throughout the United States and parts of
Canada through its network of regional bottlers and other direct
store delivery distributors, including independent Coca-Cola, Pepsi,
Cadbury Schweppes and other wholesale distributors. Boo Koo's
products are sold primarily to mainstream convenience and grocery
store chains, drug stores, gas stations and other retail outlets.
Company:              Callidus Software Inc.
Ticker Symbol & Exchange:      CALD NASDQ
Investor Relations Contact:     Jon Pexton
Investor Relations Contact Phone:  408 808 6554
Web:                www.callidussoftware.com
Date of Presentation:        5-Sep-07
Callidus Software is the leading provider of sales performance
management software and services that allow the world's largest
companies to more strategically and effectively manage sales and
incentive programs for employees and channel partners. Our best-in-
class solutions and domain expertise across a broad range of
industries enable enterprises to better align sales and incentive
strategies with corporate objectives, improve sales performance,
improve payment processing efficiency and increase profits. By
providing executives and sales management with a very clear view of
critical sales data, Callidus Software allows the connection of sales
strategies with desired business outcomes.
Company:              Captaris, Inc.
Ticker Symbol & Exchange:      CAPA
Investor Relations Contact:     MKR Group, Inc.
Investor Relations Contact Phone:  Todd Kehrli or Jim Byers, (323)
                  468-2300
Web:                www.Captaris.com
Date of Presentation:        5-Sep-07
Captaris, Inc. is a software company with products that automate paper
and document processes and manage the delivery, processing,
integration and archiving of critical documents throughout
organizations. Captaris has a large customer base, distributes its
products through a global network of partners, and targets mid size
to enterprise departmental markets.
Company:              Catalyst Pharmaceutical Partners,
                  Inc.
Ticker Symbol & Exchange:      Nasdaq: CPRX
Investor Relations Contact:     Jack Weinstein
Investor Relations Contact Phone:  201-934-4201
Web:                www.catalystpharma.com
Date of Presentation:        9/5/2007
Catalyst is a specialty pharmaceutical company focused on developing
and commercializing prescription drugs for the treatment of
addiction. Catalyst has obtained from Brookhaven National Laboratory
an exclusive worldwide license for Brookhaven's U.S. and
international patents and patents pending to use vigabatrin to treat
a wide variety of substance addictions and obsessive compulsive
disorders. Catalyst's initial product candidate based on vigabatrin
is CPP-109, which has been granted "Fast Track" status by the FDA for
the treatment of cocaine addiction. Catalyst recently initiated a 180
patient randomized, double-blind, placebo-controlled multi-center
U.S. Phase II clinical trial of CPP-109 in patients with cocaine
addiction.
Company:              China Agritech
Ticker Symbol & Exchange:      CAGC OTCBB
Investor Relations Contact:     Leslie J Richardson
Investor Relations Contact Phone:  310-231-8600
Web:                http://chinaagritechinc.com/
Date of Presentation:        9/5/2007
China Agrtiech is a China-based developer, manufacturer and marketer
of high quality, environmentally friendly liquid compound and
compound organic fertilizer products in sixteen provinces and one
municipality of China, with a thirteen year history of selling its
products in northern China and recent expansion into the western,
central and southern China. The Company relies on proprietary
production methods and formulas as part of its competitive strategy.
China Agritech has rapidly built its capacity for the production of
liquid organic compound fertilizer and plans to add organic granular
fertilizer to its product offering by the end of 2007.
Company:              China BAK Battery, Inc.
Ticker Symbol & Exchange:      CBAK
Investor Relations Contact:     Tony Shen / Tracy Li
Investor Relations Contact Phone:  86-755-89770598 / 89770093
Web:                www.bak.com.cn
China BAK Battery, Inc. is one of the largest manufacturers of
lithium-based battery cells in the world, as measured by production
output. It produces battery cells that are the principal component of
rechargeable batteries commonly used in cellular phones, notebook
computers, cordless power tools and portable consumer electronics,
such as digital media devices, portable media players, portable audio
players, portable gaming devices and PDAs (Personal Digital
Assistants). In May 2006, China BAK Battery began trading on the
NASDAQ Stock Market under the symbol CBAK.
Company:              China Biologic Products, Inc.
Ticker Symbol & Exchange:      (CBPO.PK)
Investor Relations Contact:     CCG Elite Investor Relations
Investor Relations Contact Phone:  Crocker Coulson, 646-213 1916
Web:                www.ctbb.com.cn
Date of Presentation:        4:30pm, 5th September, 2007
China Biologic Products, Inc., is a rapid growing biopharmaceutical
company, engaging in the research, production, and manufacture of
plasma-based pharmaceutical products in China. Its products include
human albumin and various innunoglobulins. Its brand "Lu Yue" enjoys
great reputation nationwide. CBPO has strong R&D team and became one
of the enterprises that first received the "Certificate of Good
Manufacturing Practices (GMP) for Pharmaceutical Products" issued by
SDA of PRC.
Company:              China-Biotics, Inc.
Ticker Symbol & Exchange:      CHBT OBBB
Investor Relations Contact:     Crocker Coulson
Investor Relations Contact Phone:  646-213-1915
Web:                http://china-
                  biotics.en.alibaba.com/
Date of Presentation:        9/6/2007
Headquartered in Shanghai, China-Biotics, Inc. was founded in 1999 and
is one of China's largest suppliers of probiotics, beneficial live
bacteria used as dietary supplements and food additives to improve
intestinal health and digestion. The Company's product portfolio
contains live microbials made with proprietary technology. Currently,
these products are sold over-the-counter under the widely recognized
"Shining" brand through large distributors to more than 1,000
pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang.
China-Biotics plans to expand its retail sales to other major cities
in China and will launch 300 Shining brand retail centers in these
cities during the next two years.
Company:              ChinaCast Education Corporation
Ticker Symbol & Exchange:      CEUC.OB (OTC)
Investor Relations Contact:     Michael J. Santos
Investor Relations Contact Phone:  86-139-1115-7131
Web:                http://ir.chinacast.com.cn
Date of Presentation:        11am, Thursday, Sept. 6, 2007
Established in 1999 and headquartered in Beijing, we are one of the
PRC's leading publicly listed e-learning and private education
service providers. ChinaCast employs over 300 employees at our
headquarters and Network Operations Center in Beijing and our offices
in Shanghai. Our customers include post-secondary and K-12
educational institutions, government agencies and corporate
enterprises. These services include interactive distance learning
applications, multimedia education content, educational portals, IT
certification/management training and English training courses.
Company:              China Housing & Land Development,
                  Inc.
Ticker Symbol & Exchange:      CHLN, OTCBB
Investor Relations Contact:     Matt Hayden
Investor Relations Contact Phone:  858-704-5065
Web:                http://chldinc.com/
Date of Presentation:        September 5, 2007 @ 3 PM
Based in Xi'an, the capital city of the Shaanxi province in China,
China Housing & Land Development, Inc. is the largest Private
developer of residential and commercial properties. China Housing has
been an independent business since 1992 and became a U.S. public
listed Company in 2006.
Company:              China Medicine Corp.
Ticker Symbol & Exchange:      CHME, OTCBB
Investor Relations Contact:     Matt Hayden
Investor Relations Contact Phone:  858-704-5065
Web:                http://www.chinamedicinecorp.com/
Date of Presentation:        September 6, 2007 @ 9 AM
China Medicine is a distributor of prescription and over the counter
pharmaceutical products, traditional Chinese medicines (finished
medicines made of Chinese herbs), Chinese herbs, nutritional
supplements, dietary supplements, medical supplies and medical
formulations to over 28 provinces and 800 customers within China. The
Company sells more than 2,200 products and is actively building a
pipeline of proprietary traditional and Chinese herbal remedy
products targeting oncology, high blood pressure and the removal of
Aflatoxins from food and animal feed.
Company:              China Security & Surveillance
                  Technology
Ticker Symbol & Exchange:      CSCT.OB
Investor Relations Contact:     Kewa Luo
Investor Relations Contact Phone:  212-588-0885 O 412-512-6655 C
Web:                www.csst.com
Date of Presentation:        September 5th 2007
Based in Shenzhen, China, China Security manufactures, distributes,
installs and maintains security and surveillance systems throughout
the PRC. China Security has manufacturing facilities located in China
and a R&D facility which maintains an exclusive collaboration
agreement with Beijing University. China Security has built a
diversified customer base through its extensive sales and service
network that includes numerous points of presence throughout the PRC.
Company:              China Shenghuo Pharmaceutical
                  Holdings
Ticker Symbol & Exchange:      KUN AMEX
Investor Relations Contact:     Crocker Coulson
Investor Relations Contact Phone:  646-213-1915
Date of Presentation:        9/6/2007
China Shenghuo Pharmaceutical Holdings, Inc., a leading traditional
Chinese pharmaceutical company, focuses on the research, development,
production and marketing of Sanchi-based medicinal products. Through
its subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd.,
China Shenghuo produces 31 State Food and Drug Association-approved
medicines, including its flagship product, Xuesaitong Soft Capsules,
which is currently listed in the nation's Insurance Catalogue.
Currently, the Company has a sales network of agencies and
representatives throughout China that markets Sanchi-based
traditional Chinese medicine to 1,650 hospitals and 1,500 drugstores
as prescription and over-the-counter treatments, primarily for
cardiovascular, cerebrovascular and peptic ulcer disease.
Company:              China Yingxia International, Inc.
Ticker Symbol & Exchange:      OTC BB: CYXI
Investor Relations Contact:     HCI Emerging Growth
Investor Relations Contact Phone:  Alan Sheinwald, 914-669-0222
Web:                [email protected]
Date of Presentation:        September 6th at 9:30 a.m.
China Yingxia International, Inc., through its 100%-owned subsidiary,
Harbin Yingxia Industrial Group Co., Ltd. ("Yingxia"), is primarily
engaged in the development, production and sales of health food
products in China. Yingxia is located in the Province of Heilongjiang
in mainland China, and it currently has over 180 employees and 3
agricultural production bases. Yingxia's products include soybean-
based foods and drinks, longgu golden millet enriched products,
cactus-based herbal supplements, personal care products, Nestle
products, and organic rice products.
Company:              Consumer Portfolio Services, Inc.
Ticker Symbol & Exchange:      CPSS - NASDAQ
Investor Relations Contact:     Robert E. Riedl
Investor Relations Contact Phone:  949-753-6800
Web:                www.consumerportfolio.com
Date of Presentation:        5-Sep-07
Consumer Portfolio Services, Inc. is a specialty finance company
engaged in purchasing and servicing new and used retail automobile
contracts originated primarily by franchised automobile dealerships
and to a lesser extent by select independent dealers of used
automobiles in the United States. We serve as an alternative source
of financing for dealers, facilitating sales to sub-prime customers,
who have limited credit history, low income or past credit problems
and who otherwise might not be able to obtain financing from
traditional sources.
Company:              Cortex Pharmaceuticals, Inc.
Ticker Symbol & Exchange:      COR
Investor Relations Contact:     Dian Griesel, IRG, New York
Investor Relations Contact Phone:  212-825-3210
Web:                www.cortexpharm.com
Date of Presentation:        9/5/2007
Cortex Pharmaceuticals, Inc. is a neuroscience company focused on the
R&D of AMPAKINE(R), a pharmacology that represents a new approach to
treat psychiatric and neurological disorders. AMPAKINE compounds are
small molecules, which positively modulate the AMPA receptor at
different binding sites in the brain. Cortex's lead product, CX717,
has demonstrated "Proof-of-Concept" in adult ADHD patients in a Phase
II study. It also improves memory in animal models for Alzheimer's
disease and may prevent respiratory depression. Other AMPAKINES may
provide a novel treatment for Huntington's disease, Rett's and
Fragile X syndromes. Cortex's partner, Organon has two AMPAKINE
compounds that are currently in Phase II studies for schizophrenia
and depression.
Company:              Cytogen Corporation
Ticker Symbol & Exchange:      Cytogen/Nasdaq
Investor Relations Contact:     Susan M. Mesco
Investor Relations Contact Phone:  609-750-8213
Web:                www.cytogen.com
Date of Presentation:        5-Sep-07
Cytogen is a specialty pharmaceutical company dedicated to advancing
the treatment and care of patients by building, developing, and
commercializing a portfolio of oncology products. The Company markets
three therapeutic products and one diagnostic product in the U.S.
CAPHOSOL(R) is an oral rinse for the treatment of oral mucositis and
dry mouth. QUADRAMET(R) (samarium Sm-153 lexidronam injection) is for
the treatment of pain in patients whose cancer has spread to the
bone. PROSTASCINT(R) (capromab pendetide) is a PSMA-targeting
monoclonal antibody-based imaging agent for prostate cancer and
SOLTAMOX(TM) (tamoxifen citrate) is a liquid hormonal therapy for
breast cancer.
Company:              DATATRAK International, Inc.
Ticker Symbol & Exchange:      DATA; Nasdaq
Investor Relations Contact:     Neal Feagans
Investor Relations Contact Phone:  Feagans Consulting; 303-449-1184
Web:                www.datatrak.net
Date of Presentation:        6-Sep-07
DATATRAK International, Inc. is a technology company providing
software in an ASP manner in order to collect, transmit, review and
store global clinical trial information for pharmaceutical,
biotechnology and medical device companies. DATATRAK assists clients
in the cost-effective accleration of clinical development in a
patient-safety-focused fashion providing real-time global access to
remotely collected information.
DATATRAK has performed 300 clinical trials and has supported users in
59 countries. The Company has assisted its clients in the development
and approval of 17 drugs and devices. Through substituting technology
for paper-based processes, DATATRAK saves more than $60 million per
approved drug and accelerates development by 45%. The market for
DATATRAK's products and services is expected to grow to $1 to $2
Billion.
Company:              Diomed Inc
Ticker Symbol & Exchange:      DIO/AMEX
Investor Relations Contact:     Carney Neonsie
Investor Relations Contact Phone:  212 213.0006
Web:                www.evlt.com
Date of Presentation:        Thursday, September 6, 2007
Diomed develops and commercializes minimally invasive medical
procedures that use its proprietary laser technologies and disposable
products. Diomed focuses on EndoVenous Laser Treatment (EVLT(R)) for
use in varicose vein treatments, photodynamic therapy (PDT) for use
in cancer treatments, and dental and general surgical applications.
The EVLT(R) procedure and the Company's related products were cleared
by the United States FDA in January of 2002. Along with lasers and
single-use procedure kits for EVLT(R), the Company provides its
customers with state of the art physician training and practice
development support. Additional information is available on the
Company's website, www.evlt.com. EVLT(R) is a registered trademark of
Diomed, Inc., Andover, MA.
Company:              EDAP TMS S.A.
Ticker Symbol & Exchange:      NASDAQ: EDAP
Investor Relations Contact:     Matt Kreps
Investor Relations Contact Phone:  469-362-5960
Web:                www.edap-tms.com
Date of Presentation:        Sept. 6
EDAP TMS S.A. develops and markets Ablatherm, the most advanced and
clinically proven choice for High Intensity Focused Ultrasound (HIFU)
treatment of localized prostate cancer. HIFU treatment is shown to be
a minimally invasive and effective treatment option with a low
occurrence of side effects. Ablatherm-HIFU is generally recommended
for patients with localized prostate cancer (stages T1-T2) who are
not candidates for surgery or who prefer an alternative option, or
for patients who failed radiotherapy treatment. EDAP TMS S.A. also
produces and commercializes medical equipment for treatment of
urinary tract stones using Extra-corporeal Shockwave Lithotripsy
(ESWL).
Company:              Forbes as one of the Middleby
                  Corporation
Ticker Symbol & Exchange:      NASDAQ: MIDD
Investor Relations Contact:     Darcy Bretz
Investor Relations Contact Phone:  847-429-7756
Web:                www.middleby.com
Date of Presentation:        9/5/2007
The Middleby Corporation is a global leader in the foodservice
equipment industry. The company develops, manufactures, markets and
services a broad line of equipment used for commercial food cooking,
preparation and processing. The company's leading equipment brands
serving the commercial foodservice industry include Blodgett(R),
Blodgett Combi(R), Blodgett Range(R), Bloomfield(R), Carter-
Hoffmann(R), CTX(R), Houno(R), Jade(R), MagiKitch'n(R), Middleby
Marshall(R), Nu-Vu(R), Pitco Frialator(R), Southbend(R),
Toastmaster(R) and Wells(R). The company's leading equipment brands
serving the food processing industry include Alkar(R), MP
Equipment(R), and RapidPak(R). The Middleby Corporation was
recognized by Business Week as a 2007 Top 100 Hot Growth Company, by
Forbes as a 2006 Best Small Company and by Crain's Chicago Business
as a 2007 Fastest Growth Company.
Company:              GameTech International
Ticker Symbol & Exchange:      GMTC
Investor Relations Contact:     John Harvat
Investor Relations Contact Phone:  (775) 850-6115
Web:                www.gametech-inc.com
Date of Presentation:        6-Sep-07
GameTech International, Inc. is in the business of designing,
manufacturing, and marketing computerized bingo and gaming equipment,
systems, and services. Under the GameTech(R) brand the company
provides electronic bingo systems and equipment. Under the Summit
Gaming(TM) brand the company provides video lottery terminals and
slot machine gaming devices. The company also provides other gaming
related equipment and services. GameTech International, Inc. is an
innovator in advanced wireless gaming applications and devices as
well as software and content for traditional slot machine games.
GameTech International, Inc. serves customers in 41 U. S. States,
Canada, Japan, Mexico, Norway, Philippines, and the United Kingdom,
and Mexico. The company was incorporated in 1994 and is headquartered
in Reno, Nevada.
Company:              Genta Incorporated
Ticker Symbol & Exchange:      NASDAQ: GNTA
Investor Relations Contact:     Tara Spiess
Investor Relations Contact Phone:  (908) 286-3980
Web:                www.genta.com
Date of Presentation:        Wednesday, September 5, 2007
Genta Incorporated is a biopharmaceutical company with a diversified
product portfolio focused on treating patients with cancer. Genta's
research platforms are anchored by programs that center on RNA- and
DNA- based medicines and small molecules. Genasense(R) (oblimersen
sodium) Injection, the Company's lead compound is in late-stage Phase
3 clinical trials. The leading small molecule, Ganite(R) (gallium
nitrate injection), is approved for marketing in the U.S. for the
treatment of cancer related hypercalcemia resistant to hydration. The
Company has an oral formulation of gallium nitrate, known as G4544,
that will enable dosing over extended periods and will enter clinical
trials in 2007.
Company:              Global Sources Ltd.
Ticker Symbol & Exchange:      NASDAQ: GSOL
Investor Relations Contact:     Suzanne Wang / Vivian Fu
Investor Relations Contact Phone:  Tel: (852) 2555 4781 / (852) 2555
                  5923
Web:                http://corporate.globalsources.com
Date of Presentation:        5-Sep-07
Global Sources is a leading B2B media company and facilitator of two-
way trade between Greater China and the rest of the world.
Its core business is facilitating trade from Greater China to the
world through a range of English-language media, including 13 online
marketplaces, 12 monthly magazines, nine trade shows and over 100
research reports.
It also facilitates trade from the world to Greater China through its
Chinese-language media targeting China's high-wealth executives and
electronics industry decision makers.
Global Sources has been facilitating global trade for 36 years. In
mainland China, it has over 1,700 team members in 44 locations.
Company:              Grill Concepts Inc.
Ticker Symbol & Exchange:      GRIL Nasdaq
Investor Relations Contact:     Angie Yang
Investor Relations Contact Phone:  310-279-5967
Web:                www.dailygrill.com
Date of Presentation:        Thursday, Sep. 6, 2007 1:30 p.m.
                  ET
Grill Concepts owns, manages and licenses upscale casual and fine
dining, full service restaurants under two core brand names: The
Grill on the Alley and Daily Grill. The company operates 27
restaurants including five The Grill on the Alley-branded restaurants
in Beverly Hills, Hollywood, San Jose, California; Chicago, Illinois;
and Dallas, Texas as well as 22 Daily Grill restaurants in Southern
and Northern California; the Washington, D.C. metropolitan region;
Houston and Austin, Texas; Portland, Oregon; Memphis, Tennessee; and
Seattle, Washington.
Company:              Gulf Resources Inc.
Ticker Symbol & Exchange:      GUFR, OTCBB
Investor Relations Contact:     Matt Hayden
Investor Relations Contact Phone:  858-704-5065
Web:                http://www.gulfresourcesco.com/
Date of Presentation:        September 6, 2007 @ 2:30 PM
Gulf Resources, Inc. operates through two wholly-owned subsidiaries:
SCHC which is engaged in manufacturing and trading Bromine and Crude
Salt in China. Bromine is used to manufacture a wide variety of
compounds utilized in industry and agriculture, and SYCI which
manufactures chemical products utilized in oil & gas field
explorations and as papermaking chemical agents.
Company:              GVI Security Solutions Inc.
Ticker Symbol & Exchange:      GVSS OTCBB
Investor Relations Contact:     Mark Collinson
Investor Relations Contact Phone:  310-231-8600 ext. 117
Web:                www.gviss.com
Date of Presentation:        9/6/2007
Headquartered in Carrollton, Texas, GVI Security Solutions, Inc.
provides video surveillance and security solutions to the homeland
security, commercial, institutional and business-to-business markets.
Samsung Electronics is GVI's primary supplier. The Company sells
Samsung's complete line of professional video surveillance and
security products in North, Central and South America. The company's
offerings include closed circuit television cameras, digital video
recorders, software and networking products that in combination
provide life safety and security for government agencies and the
private sector. Together, GVI and Samsung offer a complete line of
video surveillance services and technology.
Company:              Focus Enhancements, Inc.
Ticker Symbol & Exchange:      FCSE
Investor Relations Contact:     Kirsten Chapman / Mary Magnani
Investor Relations Contact Phone:  415-433-3777
Web:                www.focusinfo.com
Date of Presentation:        September 6th at 10:30 a.m. ET
Focus Enhancements, headquartered in Campbell, California, is a
leading developer of video production, video conversion chips and
Ultra Wideband (UWB) technology that enables wireless transmission.
UWB first applications are expected to be in the PCs and consumer
electronics industries for use in wireless USB applications like
dongles, hubs, and hard drives.
Focus has demonstrated the UWB technology transmission of a 40-feet
high definition wireless stream publicly and over 30 meters using one
antenna in the lab.
The company also has leading high-performance PC-to-TV conversion
semiconductor products that sell into the mobile markets for portable
media players, navigational devices, and smartphones.
Company:              Halozyme Therapeutics
Ticker Symbol & Exchange:      Nasdaq: HALO
Investor Relations Contact:     Eleanor Tang
Investor Relations Contact Phone:  310-691-7100
Web:                www.halozyme.com
Date of Presentation:        September 5, 2007 at 9:00 a.m. ET
Halozyme is a biopharmaceutical company developing and commercializing
products based on the extracellular matrix for the drug delivery,
oncology, and dermatology markets. The company's portfolio of
products is based on intellectual property covering the family of
human enzymes known as hyaluronidases. The company's Enhanze(TM)
Technology is a novel drug delivery platform designed to increase the
absorption and dispersion of biologics. In addition, the company has
received FDA approval for two products: Cumulase and HYLENEX, for use
as an adjuvant to increase the absorption and dispersion of other
injected drugs and fluids. The Company also has a number of different
enzymes in its portfolio that are targeting significant areas of
unmet need.
Company:              Health Grades, Inc.
Ticker Symbol & Exchange:      HGRD Nasdaq
Investor Relations Contact:     Allen Dodge
Investor Relations Contact Phone:  Allen Dodge, 303-716-0041
Web:                www.healthgrades.com
Date of Presentation:        5-Sep-07
HealthGrades is the leading ratings organization, providing ratings
and profiles of hospitals, nursing homes and physicians. Millions of
consumers and many of the nation's largest employers, health plans
and hospitals rely on HealthGrades' independent ratings and decision
support resources to make healthcare decisions based on the quality
of care. More information on the company can be found at
http://www.healthgrades.com.
Company:              HearUSA, Inc.
Ticker Symbol & Exchange:      EAR
Investor Relations Contact:     Liolios Group, Inc.
Investor Relations Contact Phone:  949-574-3860
Web:                www.hearusa.com
Date of Presentation:        Sept 6, 2007, 10:00-10:30 AM
HearUSA, Inc. provides hearing care to patients primarily through more
than 170 company-owned hearing care centers, which offer a complete
range of quality hearing aids with an emphasis on the latest digital
technology. HearUSA Centers are located in California, Florida, New
York, New Jersey, Massachusetts, Ohio, Michigan, Missouri and the
province of Ontario, Canada. The company also derives revenues from
its HearUSA Hearing Care Network, comprised of 1,600 affiliated
audiologists in 49 states, as well as its website that enables online
purchases of hearing related products, such as batteries, hearing aid
accessories and assistive listening devices. For further information,
please visit www.hearusa.com.
Company:              Hythiam, Inc.
Ticker Symbol & Exchange:      NASDAQ: HYTM
Investor Relations Contact:     Ashely Anderson
Investor Relations Contact Phone:  310-444-4343
Web:                www.hythiam.com
Date of Presentation:        5-Sep-07
Hythiam, Inc. provides behavioral health management services to health
plans, employers, criminal justice, and government agencies through a
network of licensed and company-managed providers. The company
approaches the management of behavioral health disorders with a focus
on using the latest medical and health technology towards improved
outcomes and outpatient treatment. Hythiam also researches, develops,
licenses and commercializes innovative and proprietary physiological,
nutritional, and behavioral treatment programs. The PROMETA Treatment
Program, for alcohol and stimulant dependence which integrates
behavioral, nutritional, and medical components, is available through
both licensed treatment providers and company managed PROMETA
Centers.
Company:              IMAX Corp.
Ticker Symbol & Exchange:      NASDAQ:IMAX; TSX:IMX
Investor Relations Contact:     Amanda Mullin, ICR
Investor Relations Contact Phone:  203-682-8243
Web:                www.imax.com
Date of Presentation:        5-Sep-07
IMAX Corporation is one of the world's leading entertainment
technology companies, specializing in digital and film-based motion
picture technologies. IMAX theatres deliver the world's best
cinematic presentations using proprietary IMAX, IMAX 3D, and IMAX DMR
technology. IMAX DMR is the Company's groundbreaking digital
remastering technology that allows it to digitally transform
virtually any conventional motion picture into the unparalleled image
and sound quality of The IMAX Experience. IMAX's renowned projectors
display crystal-clear images on the world's biggest screens, and the
IMAX brand is recognized throughout the world for extraordinary and
immersive entertainment experiences for consumers. As of June 30,
2007, there were 290 IMAX theatres operating in 40 countries.
Company:              International Stem Cell
                  Corporation
Ticker Symbol & Exchange:      OTCBB: ISCO
Investor Relations Contact:     William Adams, CFO
Investor Relations Contact Phone:  [email protected], 760-940-
                  6383
Web:                www.internationalstemcell.com
Date of Presentation:        Wednesday, September 5, 2007, 3 PM
International Stem Cell Corporation, www.internationalstemcell.com, is
a California company that has developed for the first time, human
stem cell lines that promise to eliminate the rejection of
transplanted cells by the patient's immune system. ISCO's technology,
Parthenogenesis, results in the creation of pluripotent human stem
cell lines from unfertilized human eggs, without the transfer of
foreign DNA. This methodology offers the potential to create the
first true "Stem Cell Bank" and also addresses critical ethical
issues by eliminating the need to use fertilized embryos. ISCO also
produces and sells specialized cells and growth media worldwide for
therapeutic research
Company:              Ironclad Perfomance Wear Corp
Ticker Symbol & Exchange:      OTC BB: ICPW.ob
Investor Relations Contact:     Anne Rakunas
Investor Relations Contact Phone:  310-954-1100
Web:                www.ironclad.com
Date of Presentation:        5-Sep
Ironclad, which created the performance work glove category in 1998,
continues to leverage its leadership position in the construction and
industrial markets through its expansion into the cross-over action
sports and outdoor enthusiast markets. With its focus on innovation,
design, advanced material science and durability, Ironclad engineers,
manufactures and sells a comprehensive line of task-specific gloves
and performance-fabric apparel. Ironclad's products are available at
hardware stores, home centers, industrial suppliers, lumber yards,
and sporting goods retailers nationwide, and in Australia, Canada,
Japan, Hungary, and the United Kingdom.
For more information on Ironclad, please visit www.ironclad.com.
Company:              ISTA Pharmaceuticals, Inc.
Ticker Symbol & Exchange:      ISTA
Investor Relations Contact:     Lauren Silvernail
Investor Relations Contact Phone:  949-788-5302
Web:                www.istavision.com
Date of Presentation:        5-Sep-07
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's
products and product candidates addressing the $3.2 billion U.S.
prescription ophthalmic industry include therapies for inflammation,
ocular pain, glaucoma, allergy, and dry eye. The Company currently
markets three products and is developing a strong product pipeline to
fuel future growth and market share. The Company's product
development and commercialization strategy is to launch a new product
every 12 to 18 months, thereby continuing its growth to become the
leading niche ophthalmic pharmaceutical company in the U.S.
Company:              Iteris, Inc.
Ticker Symbol & Exchange:      AMEX: ITI
Investor Relations Contact:     Brett Maas
Investor Relations Contact Phone:  646-536-7331
Web:                www.iteris.com
Date of Presentation:        9/5/2007
Iteris, Inc. leads the traffic management market in the development
and application of advanced technologies that reduce traffic
congestion, minimize environmental impact and improve the safety of
our surface transportation system. Combining outdoor image
processing, traffic engineering and information technology, Iteris
offers a broad range of Intelligent Transportation Systems and driver
safety solutions to customers worldwide. Iteris is headquartered in
Anaheim, California with offices throughout the U.S., Europe and Asia
Company:              Kintera
Ticker Symbol & Exchange:      KNTA
Investor Relations Contact:     Erin Leventhal
Investor Relations Contact Phone:  858.795.8979
Web:                www.kintera.com
Date of Presentation:        Sept. 6, 2007
Kintera(R), Inc. (NASDAQ: KNTA) provides software as a service to help
organizations quickly and easily reach more people, raise more money
and run more efficiently. The Kintera Sphere(R) technology platform
empowers The Giving Experience(TM), and features a social constituent
relationship management (CRM) system, enabling donor management, e-
mail and communications, Web sites, events, advocacy programs, wealth
screening and accounting.
Company:              Lakes Entertainment, Inc.
Ticker Symbol & Exchange:      Nasdaq: LACO
Investor Relations Contact:     Tim Cope
Web:                www.lakesentertainment.com
Lakes Entertainment, Inc. currently has development and management
agreements with five separate Tribes for casino operations in
Michigan, California, and Oklahoma, for a total of eight separate
casino sites. In addition, Lakes has announced plans to develop a
company owned casino resort project in Vicksburg, Mississippi. The
Company also owns approximately 61% of WPT Enterprises, Inc. (NASDAQ:
WPTE), a separate publicly held media and entertainment company
principally engaged in the development, production and marketing of
gaming themed televised programming including the World Poker Tour(R)
television series, the development and operation of an online gaming
website, the licensing and sale of branded consumer products and the
sale of corporate sponsorships.
Company:              LanOptics Ltd.
Ticker Symbol & Exchange:      NASDAQ: LNOP
Investor Relations Contact:     Ehud Helft, CCGK Investor
                  Relations
Investor Relations Contact Phone:  [email protected], 1-866-704-6710
Web:                www.lanoptics.com
Date of Presentation:        September 5, 2007 at 4:00pm
LanOptics (NASDAQ:LNOP) is focused on its majority-owned subsidiary,
EZchip Technologies Ltd., a fabless semiconductor company providing
high-speed network processors. EZchip's network processors provide
the flexibility and integration that enable triple-play data, voice
and video services in systems that make up the new Carrier Ethernet
networks. Flexibility and integration make EZchip's solutions ideal
for building systems for a wide range of applications in telecom
networks, enterprise backbones and data centers.
Company:              LiveDeal, Inc.
Ticker Symbol & Exchange:      YPNT:OTC BB
Investor Relations Contact:     John Evans
Investor Relations Contact Phone:  4803242580
Web:                www.livedeal.com
Date of Presentation:        September 5, 2007 - 1:00 PM
LiveDeal, Inc (YP Corp.). is a leader in the local online classifieds
and Yellow Pages marketplace with millions of goods and services
listed for sale in every city and zip code across the U.S. Through
its online properties LiveDeal.com and YP.com, LiveDeal offers
businesses and consumers a simple and affordable way of creating a
web presence and marketing their products and services to local
audiences. Buyers and sellers come together through LiveDeal's vast
local marketplaces to find and list business services, merchandise,
real estate, automobiles and pets. LiveDeal, Inc. is headquartered in
Mesa, Arizona. For more information, please visit LiveDeal.com.
Company:              LivePerson
Ticker Symbol & Exchange:      LPSN / NASDAQ
Investor Relations Contact:     Budd Zuckerman
Investor Relations Contact Phone:  (303) 415-0200
Web:                www.liveperson.com
Date of Presentation:        September 5th, 2007 at 1:00pm
LivePerson's hosted software enables companies to identify and
proactively engage online visitors--increasing sales, satisfaction
and loyalty while reducing service costs. Combining web-interaction
technology (chat, click-to-talk, email and self-service
knowledgebase) with a deep understanding of consumer behavior and
industry best practices, LivePerson's Timpani(TM) platform engages
the right customer, at the right time, with the right communications
channel. The platform creates more relevant, compelling and
personalized experiences--converting web traffic into revenues, and
facilitating real-time sales and customer service. More than 5,000
companies including Hewlett-Packard, Microsoft, Qwest and Verizon,
rely on LivePerson to help maximize the return on their e-commerce
investments.
Company:              Medical Action Industries Inc.
Ticker Symbol & Exchange:      MDCI
Investor Relations Contact:     Richard G. Satin
Investor Relations Contact Phone:  631-231-4600 ext 257
Web:                www.medical-action.com
Date of Presentation:        9/6/2007
Medical Action Industries Inc. develops, manufactures, markets and
supplies a variety of disposable medical products. The Company's
products are marketed to acute care facilities in domestic and
certain international markets as well as physician, dental and
veterinary offices, out-patient surgery centers, long-term care
facilities and laboratories. Medical Action is a leading manufacturer
and supplier of patient bedside utensils, containment of medical
waste, minor procedure kits and trays, sterile disposable operating
room towels and sterile disposable laparotomy sponges. The Company's
products are marketed by its direct sales personnel and extensive
network of distributors. The Company's common stock trades on the
NASDAQ Global Select Market under the symbol MDCI and is included in
the Russell 2000 Index.
Company:              Modigene Inc.
Ticker Symbol & Exchange:      OTCBB:MODG
Web:                www.modigeneinc.com
Date of Presentation:        6-Sep-07
Modigene is applying its patented CTP technology to develop longer-
acting, proprietary versions of marketed therapeutic proteins that
generate billions of dollars in annual sales. Modigene is currently
developing long-acting, CTP-modified versions of human growth
hormone, interferon beta and erythropoietin, which have demonstrated
significantly longer duration of effect and comparative biological
efficacy in animal models. Clinical trials are scheduled for 2008.
Organon has rights to CTP technology for fertility hormones only. Its
CTP follicle stimulating hormone, now in Phase lll trials,
demonstrated in Phase ll that a single injection provides the same
clinical effect as 7 daily injections of standard FSH.
Company:              NAPCO Security Systems, Inc.
Ticker Symbol & Exchange:      NASDAQ: NSSC
Investor Relations Contact:     Wolfe Axelrod Weinberger Assoc
Investor Relations Contact Phone:  Donald C. Weinberger, (212) 370-
                  4500
Web:                www.napcosecurity.com
Date of Presentation:        6-Sep-07
NAPCO Security Systems, Inc. is one of the world's leading
manufacturers of technologically advanced -electronic security
equipment including intrusion and fire alarm systems, access control
systems and electronic locking devices. The Company's products,
including those of Alarm Lock and Continental Instruments, feature
some of the most popular and best-selling control panels, sensors,
locking devices and access control products. They are used in
residential, commercial, institutional, industrial and governmental
applications. NAPCO security products have earned a reputation for
technical excellence, reliability and innovation, poising the Company
for revenue growth in the rapidly expanding electronic security
market, a market whose current size exceeds $30 billion.
Company:              Natrol, Inc.
Ticker Symbol & Exchange:      NASDAQ: NTOL
Investor Relations Contact:     ICR, James Palczynski
Investor Relations Contact Phone:  203-682-8229
Web:                www.Natrol.com
Date of Presentation:        September 5, 2007 at 8:00 a.m. EDT
Natrol, Inc. headquartered in Chatsworth, CA, has a portfolio of
health and wellness brands representing quality nutritional
supplements, functional herbal teas, and sports nutrition products.
Established in 1980, Natrol's portfolio of brands includes:
Natrol(R), MRI, Prolab(R), Laci Le Beau(R), Promensil(R),
Trinovin(R), Nu Hair(R), and Shen Min(R). The company manufactures
supplements for its own brands and on behalf of third parties.
Natrol distributes products nationally through more than 54,000
retailers, as well as internationally more than 40 countries through
distribution partners and subsidiaries in the UK and Hong Kong.
Natrol's dedication to quality is evidenced by its commitment to high
manufacturing standards, earning the company an "A" rating from the
Natural Products Association's Good Manufacturing Practices ("GMP")
Certification Program--a designation achieved by less than ten
percent of U.S. nutrition companies.
Company:              Natus Medical Incorporated
Ticker Symbol & Exchange:      BABY (Nasdaq)
Investor Relations Contact:     Steven J. Murphy
Investor Relations Contact Phone:  650-801-7236 dir 650-868-4133 cell
Web:                www.natus.com
Date of Presentation:        2007-09-06, 10:30 a.m. EST
Natus is a leading provider of healthcare products used for the
screening, detection, treatment, monitoring and tracking of common
medical ailments such as hearing impairment, neurological
dysfunction, epilepsy, sleep disorders, and newborn care. Product
offerings include computerized neurodiagnostic systems for audiology,
neurology, polysomnography, and neonatology, as well as newborn care
products such as hearing screening systems, phototherapy devices for
the treatment of newborn jaundice, head-cooling products for the
treatment of brain injury in newborns, and software systems for
managing and tracking disorders and diseases for public health
laboratories.
Additional information about Natus Medical can be found at
www.natus.com.
Company:              New Oriental Energy & Chemical
                  Corp.
Ticker Symbol & Exchange:      NOEC, NASDAQ
Investor Relations Contact:     Matt Hayden
Investor Relations Contact Phone:  858-704-5065
Web:                http://www.neworientalenergy.com/
Date of Presentation:        September 6, 2007 @ 2 PM
New Oriental Energy & Chemical Corp. is an emerging alternative fuel
and specialty chemical manufacturer based in Henan Province, China.
The Company is focused on the production of Dimethyl ether (DME),
Methanol and fertilizer products. The Company sells its products
primarily through a network of distribution partners.
Company:              Obagi Medical Products, Inc.
Ticker Symbol & Exchange:      NASDAQ: OMPI
Investor Relations Contact:     Ina McGuinness
Investor Relations Contact Phone:  310-954-1100
Web:                www.obagi.com
Date of Presentation:        1:30 p.m. (ET) on the 5th
                  Wednesday
Obagi Medical Products develops and commercializes skin health
products for the dermatology, plastic surgery, and related aesthetic
markets. Using its Penetrating Therapeutics(TM) technologies, Obagi
Medical's products are designed to improve penetration of agents
across the skin barrier for common and visible skin conditions in
adult skin including chloasma, melasma, senile lentigines, acne
vulgaris and sun damage. The history of Obagi's skin care product
introductions is as follows: Obagi Nu-Derm, 1988; Obagi-C Rx (the
first and only prescription-strength vitamin C and hydroquinone
system), 2004; Obagi Professional-C (a line of highly stable vitamin
C serums), 2005; Obagi Nu-Derm Condition and Enhance for use with
cosmetic procedures to enhance patient outcomes and satisfaction,
2006; Obagi ELASTIderm eye skin care and Obagi CLENZIderm
Company:              Overhill Farms, Inc.
Ticker Symbol & Exchange:      OFI (AMEX)
Investor Relations Contact:     John Steinbrun
Investor Relations Contact Phone:  323.582.9977
Web:                www.overhillfarms.com
Date of Presentation:        6-Sep-07
Overhill Farms is a leading value-added manufacturer of high quality,
prepared frozen food products for branded retail, private label, food
service and airline customers. Our product line includes entrees,
plated meals, bulk-packed meal components, pastas, soups, sauces,
poultry, meat and fish specialties, as well as organic and vegetarian
offerings. Our research and development efforts, combined with
proprietary recipes and flexible manufacturing capabilities, provide
customers with a one-stop solution for new product ideas,
formulations and product manufacturing, as well as precise
replication of existing recipes. Our capabilities allow customers to
outsource product development, product manufacturing and packaging
thereby avoiding significant fixed-cost and variable investments in
resources and equipment.
Company:              Pegasystems Inc.
Ticker Symbol & Exchange:      PEGA
Investor Relations Contact:     Craig Dynes
Investor Relations Contact Phone:  (617) 374-9600
Web:                http://www.pega.com
Date of Presentation:        5-Sep-07
Pegasystems, the leader in Business Process Management, provides
software to drive revenue growth, productivity and agility for the
world's most sophisticated organizations. Its award-winning
SmartBPM(R) suite helps leaders in financial services, insurance,
healthcare, government, life sciences, communications, manufacturing
and other industries improve customer service, reach new markets and
boost operational effectiveness.
Its patented SmartBPM technology makes enterprise applications easy to
build and change by directly capturing businesss objectives and
eliminating manual programming. SmartBPM unifies business rules and
processes into composite applications that leverage existing systems
-- empowering businesspeople and IT staff to Build for Change(R),
deliver value quickly and outperform their competitors.
Company:              Phoenix Technologies Ltd.
Ticker Symbol & Exchange:      PTEC
Investor Relations Contact:     Erica Mannion
Investor Relations Contact Phone:  212-766-1800
Web:                www.phoenix.com
Date of Presentation:        Wednesday, September 5, 2007
Phoenix Technologies, a global leader in system firmware, provides the
most secure foundation for computing environments. The Company
established industry leadership in 1983, has 154 technology patents,
has shipped in over one billion systems, and continues to ship in
over 125 million new systems each year. Phoenix SecureCore enables
hardware vendors to bring secure devices to market with the latest
advances in operating systems. These vendors trust Phoenix to pioneer
open standards and deliver innovative solutions to help them
accelerate time to market, differentiate products and increase
profits. Phoenix is currently working on ground-breaking technology
that will enable OEMs/ODMs to make PCs much more secure, easier to
use, more reliable and more manageable.
Company:              Points International
Ticker Symbol & Exchange:      OTCBB:PTSEF,TSX: PTS
Investor Relations Contact:     Alex Wellins / Brinlea Johnson
Investor Relations Contact Phone:  of The Blueshirt Group, 415-217-
                  7722
Web:                www.points.com
Date of Presentation:        Sept. 5th, 8:30am ET
Points International Ltd. is the owner and operator of Points.com, the
world's leading reward-program management portal. At Points.com
consumers can Swap, Earn, Buy, Gift, Share and Redeem miles and
points from more than 25 of the world's leading reward programs.
Participating programs include American Airlines AAdvantage(R)
program, American Express(R) Membership Rewards(R), Aeroplan(R),
AsiaMiles(TM), Cendant TripRewards(R), Delta SkyMiles(R), Gold Points
Reward Network, InterContinental Hotels Group's Priority Club(R)
Rewards, and S&H greenpoints. Redemption partners include
Amazon.com(R) and Starbucks.
Company:              PokerTek, Inc.
Ticker Symbol & Exchange:      PTEK, Nasdaq
Investor Relations Contact:     Julie Kramer
Investor Relations Contact Phone:  704-849-0860
Web:                www.pokertek.com
Date of Presentation:        9/6/2007
PokerTek, Inc. (NASDAQ:PTEK), headquartered in Matthews, NC, develops
and markets the PokerPro(R) system, an electronic poker table that
provides a fully-automated poker-room environment, to tribal casinos,
commercial casinos, cruise ships and card clubs. Our first product
was a 10-seated table developed in 2003, and in November 2006 we
introduced PokerPro(R) Heads-Up(TM), our 2-seated product. In June
2007 we introduced Heads-Up Challenge(TM) World Series of Poker(R)
edition, an innovative new heads-up poker table that enables two
players to compete against each other in a game of Texas Hold'em
poker for entertainment purposes. This marks our first venture into
the amusement category.
Company:              PowerSecure International, Inc.
Ticker Symbol & Exchange:      Nasdaq: POWR
Investor Relations Contact:     Sidney Hinton, president and C
Investor Relations Contact Phone:  919-453-1750
Web:                www.powersecure.com
Date of Presentation:        Sept. 5, 11:30 a.m. EDT
PowerSecure International, Inc. is a leading provider of energy
management and conservation solutions to utilities and their
commercial, institutional, and industrial customers. PowerSecure
partners with utilities to design and install Interactive Distributed
Generation(R) systems and services that manage load curtailment and
peak demand conditions, enhance system reliability and provide
customers with emergency power during outages. PowerSecure also
provides utilities with legal and regulatory consulting, energy
system engineering and construction, and energy conservation
services.
Company:              Radyne Corporation
Ticker Symbol & Exchange:      RADN
Investor Relations Contact:     Malcolm Persen
Investor Relations Contact Phone:  602-889-3226
Web:                www.radn.com
Date of Presentation:        9/5/07 at 12:00 PM
Radyne Corporation designs, manufactures, sells, integrates and
installs products, systems and software used for the transmission and
reception of data and video over satellite, troposcatter, microwave
and cable communication networks. The Company sells under four
brands:
.Radyne builds satellite modems, converters and switches.
.Xicom Technology produces high power amplifiers.
.AeroAstro is a leader in microsatellite systems, components and
advanced communications technologies.
.Tiernan is a supplier of HDTV and SDTV encoding and transmission
equipment.
Radyne is headquartered in Arizona with additional offices in
California, Virginia and Colorado. In addition the Company has sales
offices in Asia and the UK.
Company:              Rentcash Inc.
Ticker Symbol & Exchange:      TSX: RCS
Investor Relations Contact:     Michael Thompson
Investor Relations Contact Phone:  (613) 371-4093
Web:                www.rentcash.ca
Date of Presentation:        September 5th, 2007
Rentcash is the only payday advance broker in Canada publicly traded
on the Toronto Stock Exchange (TSX:RCS). Rentcash operates 425 stores
across Canada under three banners: The Cash Store, Instaloans and
Insta-rent. The Cash Store and Instaloans act as brokers to
facilitate payday advance services to income-earning consumers and
provide two private-label debit cards to those who may not be able to
obtain them from traditional banks. Insta-rent rents brand-name
furniture, appliances, electronics and computers, with our without an
option to purchase. Insta-rent operates primarily in The Brick and
United Furniture Warehouse locations, which are part of The Brick
Group, one of Canada's largest volume retailers of furniture,
appliances and home electronics. Rentcash employs 1800 associates and
is headquartered in Edmonton, Alberta.
Company:              SCOLR Pharm, Inc.
Ticker Symbol & Exchange:      DDD:AMEX
Investor Relations Contact:     Kevin McGrath, Cameron Assoc.
Investor Relations Contact Phone:  (212) 245-4577
Web:                scolr.com
Date of Presentation:        Thursday, Sept. 6, 2007 @ 2:30 PM
SCOLR Pharma, Inc. (Amex: DDD) is a specialty pharmaceutical company
utilizing its extensive formulation experience together with its
proprietary CDT(R) oral drug delivery platform to develop novel
pharmaceutical, over-the-counter, and nutritional products. SCOLR
markets its nutritional products through private label retailers in
the U.S. and partners with industry leaders for the manufacturing and
marketing of its pharmaceutical and OTC products internationally. The
Company has a strategic alliance with Perrigo to manufacture and
market its CDT sustained release nutritional supplements and has a
collaboration with Biocryst to develop an oral anti-flu formulation.
Company:              Skystar Bio-Pharmaceutical
Ticker Symbol & Exchange:      SKBI OTCBB
Investor Relations Contact:     Leslie J. Richardson
Investor Relations Contact Phone:  310-231-8600
Web:                http://www.skystarbio-
                  pharmaceutical.com
Date of Presentation:        9/6/2007
Skystar Bio-Pharmaceutical is a rapidly growing manufacturer of
medications, vaccines microorganisms, feed additives and vaccines for
farm animals and domestic pets in China. The company has a broad
portfolio of high margin Western and Traditional Chinese Medicine
products that address a full range of veterinary needs. Many of these
products focus on diseases that represent serious risk to the health
of the farm animals and the economic viability of farmers. The
increase demand for veterinary therapeutics is driven by the
modernization of the animal husbandry industry and the growing demand
for animal-based food sources resulting from the increase in living
standards in China.
Company:              SM&A
Ticker Symbol & Exchange:      WINS
Investor Relations Contact:     Jenifer Kirtland
Investor Relations Contact Phone:  415-896-6820
Web:                http://www.smawins.com
SM&A is the world's leading provider of business strategy and proposal
development services that enhance clients' ability to win competitive
procurements, and a leading provider of program management services.
SM&A has managed more than 1,000 proposals worth more than $340
billion for its clients, and has an 85% win rate on awarded
contracts. From the largest aerospace and defense contractors,
through the major software providers, to healthcare and
financial/audit service providers, SM&A is the partner many companies
turn to WHEN THEY MUST WIN.
Company:              Smart Online, Inc.
Ticker Symbol & Exchange:      SOLN
Investor Relations Contact:     Thomas Furr
Investor Relations Contact Phone:  919-765-5000
Web:                www.smartonline.com
Date of Presentation:        September 6, 2007 - 1:30 pm (edt)
Smart Online Inc. offers a private-label syndicated online business
platform that enables Software-as-a-Service (SaaS) applications and
services used to start and manage small businesses (one to fifty
employees). Our solutions are designed for the small business market
to automate and streamline business processes, reduce operating
costs, and improve internal controls. We market our business
applications to customers by private-labeling our SaaS software
services to corporations in the financial services, software,
hardware, retail, media, and telco industries. These companies
integrate Smart Online's SaaS applications onto their Web sites to
enable their existing and new business customers to run their
businesses more efficiently, and without the upfront capital
typically required for traditional business software and IT
resources.
Company:              Specialized Health Products Int'l
Ticker Symbol & Exchange:      OTC BB: SHPI
Investor Relations Contact:     Sean Collins, CCG
Investor Relations Contact Phone:  310-497-9205
Web:                www.shpi.com
Date of Presentation:        Sept. 6, 2007
Specialized Health Products International, Inc. (OTC BB: SHPI) is a
leading developer, manufacturer and marketer of proprietary
disposable medical products for clinician and patient safety.
Specialized Health Products has developed multiple safety needle
products based upon a broad intellectual property portfolio that
applies to virtually all medical needles used today. Specialized
Health Products is a market leader in safety Huber needles, with four
complementary product offerings. The Company has licensed or supplies
other products to leading global healthcare companies, including
Covidien, Bard Access Systems, and BD Medical. For more information
about Specialized Health Products, visit www.shpi.com.
Company:              SPSS Inc.
Ticker Symbol & Exchange:      Nasdaq: SPSS
Investor Relations Contact:     Janine Warell
Investor Relations Contact Phone:  312-261-6535
Web:                www.spss.com
Date of Presentation:        5-Sep-07
SPSS Inc. (Nasdaq: SPSS) is a leading global provider of predictive
analytics software and solutions. The company's predictive analytics
technology improves business processes by giving organizations
forward visibility for decisions made every day. By incorporating
predictive analytics into their daily operations, organizations
become Predictive Enterprises--able to direct and automate decisions
to meet business goals and achieve a measurable competitive
advantage. More than 250,000 public sector, academic, and commercial
customers rely on SPSS technology to help increase revenue, reduce
costs, and detect and prevent fraud. Founded in 1968, SPSS is
headquartered in Chicago, Illinois.
Company:              SRS Labs, Inc.
Ticker Symbol & Exchange:      SRSL
Investor Relations Contact:     Ulrich Gottschling
Investor Relations Contact Phone:  949-442-1070
Web:                srslabs.com
Date of Presentation:        CEO, Tom Yuen - September 6, 2007
SRS Labs is a leader in audio signal processing for consumer
electronics. Founded in 1993, SRS Labs holds 129 worldwide patents,
with another 34 pending, for advanced audio, voice and surround sound
technologies that optimize and improve the listening experience
through techniques based on research into the human auditory system.
Through partnerships with leading global manufacturers and
semiconductor and software partners, over one billion products have
shipped worldwide utilizing SRS audio technologies. SRS Labs audio
and voice processing provides the best possible sound from all
content and in every environment including HDTVs, mobile phones,
portable media devices, A/V components, PCs and automotive
entertainment. SRS Labs supports manufacturers worldwide with offices
in the US, China, Europe, Japan, Korea and Taiwan.
Company:              StockerYale
Ticker Symbol & Exchange:      NASDAQ: STKR
Investor Relations Contact:     Melissa Dixon
Investor Relations Contact Phone:  212-481-2050 / 917-238-3189
Web:                www.stockeryale.com
Date of Presentation:        5-Sep-07
StockerYale, Inc., headquartered in Salem, New Hampshire, is an
independent designer and manufacturer of structured light lasers, LED
modules, and specialty optical fibers for industry leading OEMs. In
addition, the company manufactures fluorescent lighting products and
phase masks. The Company serves a wide range of markets including the
machine vision, industrial inspection, defense, telecommunication,
sensors, and medical markets. StockerYale has offices and
subsidiaries in the U.S., Canada, and Europe. For more information
about StockerYale and their innovative products, visit the Company's
web site at www.stockeryale.com
Company:              Terabeam
Ticker Symbol & Exchange:      NASDAQ: TRBM
Investor Relations Contact:     Bert Williams
Investor Relations Contact Phone:  408-731-2610
Web:                www.terabeam.com
Date of Presentation:        5-Sep-07
Terabeam, Inc.'s (NASDAQ:TRBM) business is conducted primarily through
its subsidiary Proxim Wireless Corporation. Proxim Wireless is a
leader in core-to-client solutions for broadband municipal wireless
networks. Our systems enable a variety of wireless applications
including security and surveillance systems, mobile workforce
automation and machine-to-machine communications. We have shipped
more than 1.5 million wireless devices to more than 200,000 customers
worldwide. Additional information about the company can be found at
the company's website located at www.terabeam.com or by contacting
the company by telephone at 408-731-2610 or by email at
[email protected].
Company:              Trinity Biotech plc
Ticker Symbol & Exchange:      TRIB . NASDAQ
Investor Relations Contact:     Ms. Niamh Long
Investor Relations Contact Phone:  353 1 2743266
Web:                www.trinitybiotech.com
Date of Presentation:        Wednesday September 5th 2007
Trinity Biotech develops, acquires, manufactures and markets
diagnostic systems, including both reagents and instrumentation, for
the point-of-care and clinical laboratory segments of the diagnostic
market. The products are used to detect infectious diseases and blood
coagulation disorders, and to quantify the level of Haemoglobin A1c
and other chemistry parameters in serum, plasma and whole blood.
Trinity Biotech sells direct in the United States, Germany, France
and the U.K. and through a network of international distributors and
strategic partners in over 75 countries worldwide. For further
information please see the Company's website - www.trinitybiotech.com
Company:              Trintech Group plc
Ticker Symbol & Exchange:      TTPA NASDAQ
Investor Relations Contact:     Valerie Ivers
Investor Relations Contact Phone:  011 353 1 2939850
Web:                www.trintech.com
Date of Presentation:        6-Sep-07
Trintech is a leading provider of financial governance, transaction
risk management and compliance solutions for the commercial,
financial, and healthcare markets worldwide.
Over 500 leading global organizations, including 16 of the Fortune 50,
realize the benefits of Trintech solutions every day to: improve
performance through stronger management of the revenue cycle and
disbursements; ensure the accuracy and integrity of financial data;
identify and reduce transaction risk; improve the quality and
timelines of financial reporting and strengthen internal controls to
support compliance requirements.
Approximately 65% of the Company's revenue is recurring. Presenting at
Roth New York conference on September 6.
Company:              Unigene Laboratories, Inc.
Ticker Symbol & Exchange:      UGNE OTC BB
Investor Relations Contact:     Daniel Berg
Investor Relations Contact Phone:  212-825-3210
Web:                www.unigene.com
Date of Presentation:        5-Sep-07
Unigene Laboratories, Inc. is a biopharmaceutical company engaged in
the research, production, and delivery of valuable therapeutic
peptide hormones for pharmaceutical purposes. We have patented
manufacturing technology for producing peptides cost-effectively and
in quantities sufficient to support the worldwide commercialization
of peptide therapeutics in convenient dosage forms. We have also
patented novel oral and nasal delivery technology that has been shown
to effectively deliver significant levels of therapeutically
important peptides. Fortical(R), our nasal spray formulation of
calcitonin for the treatment of osteoporosis, received FDA approval
and was launched in August 2005.
Company:              Winner Medical Group INC.
Ticker Symbol & Exchange:      OTCBB: WMDG
Investor Relations Contact:     Annie Chen / Anne Pang
Investor Relations Contact Phone:  86 755 28066858 / 605 610 4278
Web:                www.winnermedical.com
Date of Presentation:        6th September 2007
Winner Medical Group Inc. is a holding company primarily engaged in
the development, manufacturing and distribution of high-quality
cotton disposable medical dressings and disposable products.
Winner Medical products are manufactured in China and sold in
countries including Japan, Germany, Italy, the Netherlands,
Australia, France, China, the United States, South America, Africa
and the Middle East. It has been the largest exporter of surgical
dressings from 2002 to 2006.
Winner Medical is one of few Chinese companies licensed by the U.S.
Food and Drug Administration to ship finished, sterilized products
directly to the U.S. market. It has also gained ISO 9001: 2000, ISO
13485: 2003 and CE certification.
Company:              WPT Enterprises, Inc.
Ticker Symbol & Exchange:      NASDAQ: WPTE
Investor Relations Contact:     Allyson Pooley
Investor Relations Contact Phone:  310-954-1100
Web:                www.worldpokertour.com
Date of Presentation:        Sep. 6 - 8:30 a.m. ET
WPTE is a company engaged in the creation of internationally branded
entertainment and consumer products driven by the development,
production, and marketing of televised programming based on gaming
themes. WPTE is the creator of the World Poker Tour(R), a television
show based on a series of high-stakes poker tournaments that airs on
the Travel Channel in the United States and is scheduled to begin
broadcasting on GSN in early 2008. The World Poker Tour television
series is licensed for broadcast globally. WPTE also offers real-
money online gaming on its website, www.worldpokertour.com, which
prohibits wagers from players in the U.S. and certain other
restricted territories.
Company:              Xcorporeal
Investor Relations Contact:     Robert Weinstein, CFO
Investor Relations Contact Phone:  310-424-5738,
                  [email protected]
Date of Presentation:        5-Sep-07
Xcorporeal is a development stage medical device company that has
developed an innovative platform technology that may potentially
replace the function of various human organs. The four products that
it plans to market are an ultrafiltration device for congestive heart
failure (CHF), devices for home and hospital renal replacement
therapy (RRT), and the Wearable Artificial Kidney (WAK). These
devices will provide patients with improved, efficient and cost
effective therapy. A prototype of the ultrafiltration device and the
WAK has been successfully tested in human subjects. The CHF and RRT
markets represent multibillion dollar opportunities for Xcorporeal
and the Company plans to commercialize the CHF device in 2008.
Company:              Yucheng Technologies Limited
Ticker Symbol & Exchange:      NASDAQ: YTEC
Investor Relations Contact:     Wei Peng
Investor Relations Contact Phone:  8610-64420533
Web:                www.yuchengtech.com
Date of Presentation:        6-Sep
Yucheng Technologies Limited (NASDAQ: YTEC) is a leading IT and
outsourced service provider to the Chinese banking industry.
Headquartered in Beijing, China, Yucheng has more than 1,200
employees and nine subsidiaries and representative offices across the
country. Yucheng's product and service offerings include system
integration and IT consulting, solutions and software platform, and
outsourced operations. Yucheng counts 13 top banks in China as its
customers, and is especially strong in banking channel management IT
solutions and services, such as web banking, call centers, and
risk/performance management solution consulting and implementation
service as well as POS merchant acquiring services.
Company:              Zhongpin
Ticker Symbol & Exchange:      ZHNP OTCBB
Investor Relations Contact:     Crocker Coulson
Investor Relations Contact Phone:  646-213-1915
Web:                www.zpfood.com
Date of Presentation:        9/6/2007
Zhongpin specializes in processing pork and pork products, and fruits
and vegetables in China. The Company is developing a nationally
recognized high quality brand for meats and food products. The
Company has a complete state-of-the-art vertically-integrated fresh
meat and meat products supply chain from farming, slaughtering,
cutting, processing and wholesaling to retailing. It sells its
products domestically through its Zhongpin speciality stores, food
retailers, foodservice distributors, restaurant operators and
noncommercial foodservice establishments. The Company also has
established strategic partnerships with leading supermarket chains
for exclusive branded counters and major catering companies in the
PRC.



Note to Editors: Business Wire's PressPass allows you to create free, custom Web, RSS, and email-based news feeds from more than 160 industry options, dozens of subject categories and thousands of geographic preferences as well as by specific company filters. In addition, PressPass subscribers have access to exclusive content, experts, company profiles, email alerts, survey services and other media services.


Note to Event Organizers: Add your trade show, conference, or event to http://www.tradeshownews.com, Business Wire's online event calendar. For information, email [email protected].

[ Back To TMCnet.com's Homepage ]